Nir Hus
Surgical Critical Care · Delray Beach, FLNPI 1699081117
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 42 manufacturers reported payments, led by Integra Lifesciences Corporation at 25.9% of the total. Reporting peaked in 2023 at $91,442 and has fallen 74.7% since, to $23,127 in 2025. Among surgical critical care clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 604 payments — averaging $732.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$114K
- Medical Device Business Services, Inc.$87K
- Acell, Inc.$85K
- Atricure, Inc.$64K
- Aroa Biosurgery Incorporated$31K
- Zimmer Biomet$27K
- plus $35K from 36 others
Across 3 payments — averaging $52,403 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$157K
What the payments were for
- Consulting fees$258,70458%
- Speaking & faculty fees$96,56522%
- Travel & lodging$62,55114%
- Food & beverage$12,1423%
- Education$12,4883%
- Gifts$960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$162,725
- MATRIXRIB$90,304
- NA$61,272
- RIBFIX BLU ADVANTAGE$27,305
- CYTAL$27,037
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$25,831
- NEURAGEN$18,183
- PRIMATRIX$17,063
- ATRICURE CRYOSURGICAL SYSTEM$12,539
- XCM BIOLOGIC$11,060
- V.A.C. ULTA$10,208
- DAVINCI XI$10,000
- Curos$9,859
- ATTEST$9,859
- 3M SoluPrep$9,859
- KERRAMAX CARE$9,859
- INTEGRA DERMAL REGENERATION TEMPLATE$8,782
- ADVANCED WOUND CARE$8,580
- XCM Biologic Tissue Matrix$8,192
- CMF & Thoracic-None$6,133
How this compares
$442,545 in reported general payments places this provider in the 95th percentile of 132 surgical critical care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $89 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in Delray Beach
- Alfredo CordovaSarasota$314K
- Joshua CarsonGainesville$52K
- Jose DiazTampa$35K
- Anthony GielowLongwood$29K
- Chadwick SmithOrlando$23K
- Scott ZenoniMelbourne$22K
- Frederick MooreGainesville$20K
- Carl SchulmanMiami$17K
- Chasen CroftGainesville$17K
- Emily HelmickOrlando$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.